Literature DB >> 30892520

Factors associated with glycemic control in people with diabetes mellitus.

Mariana Angela Rossaneis1, Selma Maffei de Andrade2, Raquel Gvozd1, Paloma de Souza Cavalcante Pissinati1, Maria do Carmo Lourenço Haddad1.   

Abstract

Investigate the factors associated with the glycemic control in people with diabetes mellitus (DM). Cross-sectional study with 746 people with type-2 DM of age 40 or older. The following variables were selected: socioeconomic, clinical data, lifestyle and the risk of developing foot ulcers. Data collection occurred through interviews, medical record analysis and clinical examination of the lower limbs. We used the Poisson multiple regression model to determine the crude and adjusted prevalence ratios (PR) of the glycemic alteration. The alteration in the glycated hemoglobin (HbA1c) test was considered as a dependent variable in this study, which has been classified as high when the result was higher than 7%. The alteration in HbA1c was present in 68.9% of the participants and was more prevalent in individuals aged between 50 and 69 (PR = 1.38/IC95% = 1.09-1.75), who were taking insulin (PR = 1.35/IC95% = 1.24-1.47), obese (PR = 1.14/IC95% = 1.03-1.25) and who had foot ulceration risk (PR = 1.14/IC95% = 1.09-1.28). Individuals aged between 50 and 69; the ones who used insulin; the obese ones; and those who had a risk of foot ulceration, presented higher prevalence rates of alteration in the glycated hemoglobin.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30892520     DOI: 10.1590/1413-81232018243.02022017

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  2 in total

1.  Poor glycemic control and associated factors in diabetic people attending a reference outpatient clinic in Mato Grosso, Brazil.

Authors:  Mariano Martínez Espinosa; Vitesinha Rosa Dos Santos Almeida; Vagner Ferreira do Nascimento
Journal:  Invest Educ Enferm       Date:  2021-10

2.  The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Lexun Wang; Lei Xiang; Shenghua Piao; Xiao Gong; Wanxing Zhou; Weixun Feng; Huilin Li; Leyu Li; Aisheng Wei; Qing Zhu; Xianglu Rong; Jiao Guo
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-14       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.